FDA Drug recall D-0575-2025
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Au…
- FDA Drug
- Class II
- ongoing
- Published 2025-08-20
On 2025-08-20 the FDA classified a Class II recall of Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Au… by Pfizer, citing subpotent drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0575-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2025-07-29 |
| Published | 2025-08-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Pfizer |
| Distribution | n/a |
Product
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Reason
Subpotent drug
Identifiers
| ndc | 60793-850-10 |
|---|---|
| ndc | 60793-850-01 |
| ndc | 60793-851-10 |
| ndc | 60793-851-01 |
| ndc | 60793-852-10 |
| ndc | 60793-852-01 |
| ndc | 60793-853-10 |
| ndc | 60793-853-01 |
| ndc | 60793-854-10 |
| ndc | 60793-854-01 |
| ndc | 60793-855-10 |
| ndc | 60793-855-01 |
| ndc | 60793-856-10 |
| ndc | 60793-856-01 |
| ndc | 60793-857-10 |
| ndc | 60793-857-01 |
| ndc | 60793-858-10 |
| ndc | 60793-858-01 |
| ndc | 60793-859-10 |
| ndc | 60793-859-01 |
| ndc | 60793-860-10 |
| ndc | 60793-860-01 |
| code_info | Lot #: 24C11, Exp 2/28/2026. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0575-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.